Exodus Point Capital Management, LP Aclaris Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$6.56 - $10.95 $960,738 - $1.6 Million	146,454 New	146,454 $1 Million
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $211,410 - $271,012	14,753 New	14,753 $232,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $387,685 - $544,730	-28,975 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $1.91 Million - $3.31 Million	-111,880 Reduced 79.43%	28,975 $509,000
Q1 2021 May 17, 2021	SELL	$5.86 - $27.73 $479,306 - $2.27 Million	-81,793 Reduced 36.74%	140,855 $3.55 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $590,017 - $1.69 Million	222,648 New	222,648 $1.44 Million

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.